Working... Menu

Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00243854
Recruitment Status : Completed
First Posted : October 25, 2005
Last Update Posted : March 18, 2014
Genentech, Inc.
Information provided by (Responsible Party):
Indiana University ( Indiana University School of Medicine )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : October 2011